Neuroone Medical Technologies Corp
NMTC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001500198
In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 1 sale; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Neuroone Medical Technologies Corp as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −2 vs. Q4 2023
- Shares held
- 4.30M
- −16.1K (−0.4%) vs. Q4 2023
- Total value
- $5.16M
- −$1.66M (−24.3%) vs. Q4 2023
- New holders
- 1
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $6.21M |
| Q1 2026 | 32 | $9.14M |
| Q4 2025 | 37 | $9.44M |
| Q3 2025 | 34 | $12.8M |
| Q2 2025 | 31 | $9.80M |
| Q1 2025 | 19 | $2.63M |
| Q4 2024 | 21 | $2.30M |
| Q3 2024 | 22 | $3.59M |
| Q2 2024 | 19 | $2.95M |
| Q1 2024 | 19 | $5.16M |
| Q4 2023 | 21 | $6.81M |
| Q3 2023 | 20 | $3.71M |
| Q2 2023 | 15 | $1.79M |
| Q1 2023 | 16 | $2.44M |
| Q4 2022 | 21 | $1.53M |
| Q3 2022 | 12 | $2.99M |
| Q2 2022 | 11 | $1.51M |
| Q1 2022 | 12 | $2.33M |
| Q4 2021 | 17 | $6.52M |
| Q3 2021 | 9 | $4.94M |
| Q2 2021 | 4 | $9.36M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Neuroone Medical Technologies Corp; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 1,450,000 | $1.74M | 0.23% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,198,912 | $1.44M | 0.14% | −15,182−1.3% | Reduced |
| Vanguard Group Inc | 919,321 | $1.10M | 0.00% | +1,691+0.2% | Added |
| Geode Capital Management, LLC | 221,949 | $266.4K | 0.00% | +24,828+12.6% | Added |
| Mayo Clinic | 181,754 | $218.1K | 3.55% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 150,000 | $180.0K | 0.15% | 00.0% | Unchanged |
| State Street Corp | 51,599 | $61.9K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 50,000 | $60.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 30,281 | $36.3K | 0.00% | 00.0% | Unchanged |
| Princeton Global Asset Management LLC | 16,833 | $20.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,310 | $13.6K | 0.00% | +11,310 | New |
| Tower Research Capital LLC (TRC) | 7,002 | $8.40K | 0.00% | +1,865+36.3% | Added |
| Centerpoint Advisors, LLC | 5,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,720 | $2.00K | 0.00% | −1,200−41.1% | Reduced |
| Nemes Rush Group LLC | 433 | $520 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 350 | $420 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 193 | $232 | 0.00% | +18+10.3% | Added |
| UBS Group AG | 108 | $130 | 0.00% | −1,777−94.3% | Reduced |
| JPMorgan Chase & Co | 55 | $66 | 0.00% | +16+41.0% | Added |
| Wealth Alliance Advisory Group, LLC | 0 | $0 | 0.00% | −19,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,117−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −30−100.0% | Sold out |